Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Luzzago, Stefano"'
Autor:
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Hospital of Tours, Tours, France., D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Rosiello G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada.; Department of Urology and Division of Experimental Oncology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy., Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada.; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Pecoraro A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada.; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy., Palumbo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada.; Urology Unit, Department of Medical and Surgical Specialties, ASST Spedali Civili of Brescia, Brescia, Italy.; Radiological Science and Public Health, University of Brescia, Brescia, Italy., Knipper S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada.; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada., Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Sari Motlagh R; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Mostafaei H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Schuettfort VM; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria - shahrokh.shariat@meduniwien.ac.at.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan.; European Association of Urology Research Foundation, Arnhem, the Netherlands.
Publikováno v:
Minerva urology and nephrology [Minerva Urol Nephrol] 2022 Jun; Vol. 74 (3), pp. 329-336. Date of Electronic Publication: 2021 Mar 26.
Autor:
Pecoraro A; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy. Electronic address: pecoraroangela@libero.it., Deuker M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany., Rosiello G; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy., Stolzenbach F; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Luzzago S; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy., Tian Z; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada., Shariat SF; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Saad F; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada., Briganti A; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy., Kapoor A; Division of Urology, McMaster University, Hamilton, Ontario, Canada., Fiori C; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Porpiglia F; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada.
Publikováno v:
Urologic oncology [Urol Oncol] 2021 Apr; Vol. 39 (4), pp. 239.e1-239.e7. Date of Electronic Publication: 2021 Feb 16.
Autor:
Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: stefanoluzzago@gmail.com., Rosiello G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Pecoraro A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy., Deuker M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Frankfurt, Frankfurt Am Main, Germany., Stolzenbach F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mistretta FA; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Musi G; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Montanari E; Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Briganti A; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., de Cobelli O; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
Publikováno v:
Surgical oncology [Surg Oncol] 2021 Mar; Vol. 36, pp. 131-137. Date of Electronic Publication: 2020 Dec 11.
Autor:
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University Hospital of Tours, Tours, France., D Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Rosiello G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada; Division of Experimental, OncologyDepartment of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy., Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Pecoraro A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy., Palumbo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada; Urology Unit, Department of Medical and Surgical Specialties, ASST Spedali Civili of Brescia, Radiological Science and Public Health, University of Brescia, Brescia, Italy., Knipper S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada., Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX., Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Sari Motlagh R; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Mostafaei H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern, Dallas, TX; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan; European Association of Urology Research Foundation, Arnhem, Netherlands. Electronic address: shahrokh.shariat@meduniwien.ac.at.
Publikováno v:
Urologic oncology [Urol Oncol] 2020 Dec; Vol. 38 (12), pp. 936.e7-936.e14. Date of Electronic Publication: 2020 Sep 19.
Autor:
Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: stefanoluzzago@gmail.com., Palumbo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia. Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Italy., Rosiello G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Pecoraro A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy., Deuker M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany., Stolzenbach F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mistretta FA; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Musi G; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Montanari E; Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Departments of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern, Dallas, TX; Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Briganti A; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., de Cobelli O; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
Publikováno v:
Urology [Urology] 2020 Jun; Vol. 140, pp. 91-97. Date of Electronic Publication: 2020 Mar 06.
Autor:
Rosiello G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: giusepperosiello@hotmail.it., Palumbo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia. Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Italy., Knipper S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Pecoraro A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy., Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy., Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Larcher A; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Capitanio U; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Montorsi F; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute of Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Briganti A; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
Publikováno v:
Urologic oncology [Urol Oncol] 2020 May; Vol. 38 (5), pp. 537-544. Date of Electronic Publication: 2020 Feb 29.
Autor:
Vartolomei MD; Division of Urology, European Institute of Oncology, Milan, Italy; Department of Cell and Molecular Biology, University of Medicine and Pharmacy, Tirgu Mures, Romania., Matei DV; Division of Urology, European Institute of Oncology, Milan, Italy; Department of Urology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania., Renne G; Department of Laboratory and Pathology, European Institute of Oncology, Milan, Italy., Tringali VM; Division of Urology, European Institute of Oncology, Milan, Italy., Crisan N; Division of Urology, European Institute of Oncology, Milan, Italy; Department of Urology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania., Musi G; Division of Urology, European Institute of Oncology, Milan, Italy., Mistretta FA; Division of Urology, European Institute of Oncology, Milan, Italy., Russo A; Division of Urology, European Institute of Oncology, Milan, Italy., Cozzi G; Division of Urology, European Institute of Oncology, Milan, Italy., Cordima G; Division of Urology, European Institute of Oncology, Milan, Italy., Luzzago S; Division of Urology, European Institute of Oncology, Milan, Italy., Cioffi A; Division of Urology, European Institute of Oncology, Milan, Italy., Di Trapani E; Division of Urology, European Institute of Oncology, Milan, Italy., Catellani M; Division of Urology, European Institute of Oncology, Milan, Italy., Delor M; Division of Urology, European Institute of Oncology, Milan, Italy., Bottero D; Division of Urology, European Institute of Oncology, Milan, Italy., Imbimbo C; Division of Urology, University of Naples Federico II, Italy., Mirone V; Division of Urology, University of Naples Federico II, Italy., Ferro M; Division of Urology, European Institute of Oncology, Milan, Italy. Electronic address: matteo.ferro@ieo.it., de Cobelli O; Division of Urology, European Institute of Oncology, Milan, Italy; University of Milan, Milan, Italy.
Publikováno v:
European urology focus [Eur Urol Focus] 2019 Jul; Vol. 5 (4), pp. 636-641. Date of Electronic Publication: 2017 Oct 27.
Autor:
Vartolomei MD; Department of Urology, European Institute of Oncology, Milan, Italy.; Department of Cell and Molecular Biology, University of Medicine and Pharmacy, Tirgu Mures, Romania., Matei DV; Department of Urology, European Institute of Oncology, Milan, Italy.; Department of Urology, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania., Renne G; Department of Laboratory and Pathology, European Institute of Oncology, Milan, Italy., Tringali VM; Department of Urology, European Institute of Oncology, Milan, Italy., Crișan N; Department of Urology, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania., Musi G; Department of Urology, European Institute of Oncology, Milan, Italy., Mistretta FA; Department of Urology, European Institute of Oncology, Milan, Italy., Russo A; Department of Urology, European Institute of Oncology, Milan, Italy., Conti A; Department of Urology, European Institute of Oncology, Milan, Italy., Cozzi G; Department of Urology, European Institute of Oncology, Milan, Italy., Luzzago S; Department of Urology, European Institute of Oncology, Milan, Italy., Catellani M; Department of Urology, European Institute of Oncology, Milan, Italy., Cioffi A; Department of Urology, European Institute of Oncology, Milan, Italy., Cordima G; Department of Urology, European Institute of Oncology, Milan, Italy., Bianchi R; Department of Urology, European Institute of Oncology, Milan, Italy., Di Trapani E; Department of Urology, European Institute of Oncology, Milan, Italy., Serino A; Department of Urology, European Institute of Oncology, Milan, Italy., Delor M; Department of Urology, European Institute of Oncology, Milan, Italy., Bianco R; Department of Urology, European Institute of Oncology, Milan, Italy., Bottero D; Department of Urology, European Institute of Oncology, Milan, Italy., Ferro M; Department of Urology, European Institute of Oncology, Milan, Italy - matteo.ferro@ieo.it., De Cobelli O; Department of Urology, European Institute of Oncology, Milan, Italy.; University of Milan, Milan, Italy.
Publikováno v:
Minerva urologica e nefrologica = The Italian journal of urology and nephrology [Minerva Urol Nefrol] 2019 Feb; Vol. 71 (1), pp. 31-37. Date of Electronic Publication: 2018 Sep 19.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Piazza, Pietro, Bianchi, Lorenzo, Luzzago, Stefano, Bandini, Marco, Mottaran, Angelo, Amirhassankhani, Sasan, Puliatti, Stefano, De Concilio, Bernardino, Celia, Antonio, Serra, Carla, Cappelli, Alberta, Golfieri, Rita, Musi, Gennaro, Gallina, Andrea, Rizzo, Michele, Liguori, Giovanni, Trombetta, Carlo, Schiavina, Riccardo, De Cobelli, Ottavio, Montorsi, Francesco
Publikováno v:
Journal of Urology; 2024 Supplement 5, Vol. 211, pe1105-e1105, 1p